SG
KANG

Societe Generale’s iKang Healthcare Group, Inc. KANG Stock Holding History

Societe Generale’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$2.39M Buy
+130,106
New +$2.62M 0.02% 749

Other funds holding KANG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
ASI
All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Societe Generale's KANG Position: Q2 2016 in Review

Societe Generale opened a new position in iKang Healthcare Group, Inc. (KANG) in Q2 2016: 130,106 shares worth $2.39M. The stake represents 0.02% of the portfolio and ranks #749 among its holdings.

66 funds tracked by Wall St. Rank hold KANG as of Q2 2016.

  • Societe Generale held 130,106 shares of iKang Healthcare Group, Inc. worth $2.39M as of Q2 2016.
  • iKang Healthcare Group, Inc. was a new Societe Generale position in Q2 2016.
  • iKang Healthcare Group, Inc. made up 0.02% of Societe Generale's portfolio in Q2 2016, its #749 holding.
  • 66 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.